Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Review
. 2017 Jan;83(1):82-87.
doi: 10.1111/bcp.13041. Epub 2016 Jul 28.

Recombinant biologic products versus nutraceuticals from plants - a regulatory choice?

Pascal M W Drake  1 , Tim H Szeto  1 , Mathew J Paul  1 , Audrey Y-H Teh  1 , Julian K-C Ma  1
Affiliations
Review

Recombinant biologic products versus nutraceuticals from plants - a regulatory choice?

Pascal M W Drake et al. Br J Clin Pharmacol. 2017 Jan.

Abstract

Biotechnology has transformed the potential for plants to be a manufacturing source of pharmaceutical compounds. Now, with transgenic and transient expression techniques, virtually any biologic, including vaccines and therapeutics, could be manufactured in plants. However, uncertainty over the regulatory path for such new pharmaceuticals has been a deterrent. Consideration has been given to using alternative regulatory paths, including those for nutraceuticals or cosmetic agents. This review will consider these possibilities, and discuss the difficulties in establishing regulatory guidelines for new pharmaceutical manufacturing technologies.

Keywords: GMP; manufacturing; monoclonal antibody; recombinant pharmaceutical; transgenic plants.

PubMed Disclaimer

References

    1. Gurib‐Fakim A. Medicinal plants: traditions of yesterday and drugs of tomorrow. Mol Aspects Med 2006; 27: 1–93. - PubMed
    1. Raskin I, Ribnicky DM, Komarnytsky S, Ilic N, Poulev A, Borisjuk N, et al. Plants and human health in the twenty‐first century. Trends Biotechnol 2002; 20: 522–31. - PubMed
    1. Hefferon KL. Nutritionally enhanced food crops; progress and perspectives. Int J Mol Sci 2015; 16: 3895–914. - PMC - PubMed
    1. Paul MJ, Thangaraj H, Ma JK. Commercialization of new biotechnology: a systematic review of 16 commercial case studies in a novel manufacturing sector. Plant Biotechnol J 2015; 13: 1209–20. - PubMed
    1. Ma JK, Drossard J, Lewis D, Altmann F, Boyle J, Christou P, et al. Regulatory approval and a first‐in‐human phase I clinical trial of a monoclonal antibody produced in transgenic tobacco plants. Plant Biotechnol J 2015; 13: 1106–20. - PubMed

Publication types

MeSH terms